ArticleInternational journal of environmental research and public health2021

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome.

Habiba Shabir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.